The majority of human illnesses is caused by damage of a single organ like the liver whose failure accounts for 2M deaths worldwide every year. Orthotopic transplants are the only curative therapy ...

Vertical integration for CDMOs in manufacturing ADCs offers an opportunity to reduce costs and create a more resilient supply ...

Directors at a family-owned paper products business have told Insider about the Lancashire firm's rapid growth since being established in 2019 and how they hope to push turnover up ...

Novartis will invest about $70M to build a Florida radioligand therapy plant, expanding its U.S. cancer drug manufacturing ...

A test that rapidly detects signs of inflammatory bowel disease (IBD) in stool samples could improve future diagnosis and ...

Novartis has announced plans to construct a radioligand therapy (RLT) manufacturing facility in Winter Park, Florida, as part ...

A test that rapidly detects signs of inflammatory bowel disease (IBD) in stool samples could improve future diagnosis and monitoring of the condition, a study suggests.

Challenges remain, like regulatory hurdles and funding, but our team's grit and your support as shareholders make me ...

New 35,000-square-foot facility in Winter Park will expand RLT manufacturing footprint to optimize delivery for patients across southeastern ...

Whether it’s a pain in the neck, hands or elsewhere, workplace ergonomics programs must address risks and improper behavior ...

Angola, the DRC, and Zambia have positioned the corridor as a flagship, with financial and political backing from the United ...

Novartis to build its fourth US radioligand therapy manufacturing facility in Winter Park, Florida with an investment of $23 billion: Basel Monday, January 12, 2026, 10:00 Hrs [IS ...